CLINICAL TRIAL
Treatment for Scoliosis; Lumbar Region
Recruiting · < 65 · All Sexes · Manhattan, NY
Incobotulinumtoxin A and Yoga-like Isometric Exercise in Adolescent Idiopathic Lumbar Scoliosis
See full descriptionAbout the trial for Scoliosis; Lumbar Region
Eligible Conditions
Scoliosis; Lumbar Region · Scoliosis; Adolescence · Scoliosis · Scoliosis Idiopathic
Treatment Groups
This trial involves 4 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. Some patients will receive a placebo treatment. The treatments being tested are in Phase 2 and have already been tested with other people.
Botulinum toxin type A
DRUG
+
Isometric Yoga-like exercise
BEHAVIORAL
Placebo
BEHAVIORAL
Botulinum toxin type A
DRUG
Eligibility
This trial is for patients born any sex aged 65 and younger. There is one eligibility criterion to participate in this trial as listed below.
Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:View All
1. Fourteen - 18 years of age, 2. Scoliotic curve greater than 25 degrees, less than 45 degrees, 3. Stated willingness to do the yoga and yoga-like poses daily, 4. Written, signed consent by patient and parent/guardian 5. Pre-test Cobb films no less than 3 months old read by independent radiologists.
Odds of EligibilitySimilar Trials
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Approximate Timelines
Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 3 months after crossover group injections
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months after crossover group injections
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like
Measurement Requirements
This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Scoliosis; Lumbar Region. Measurement will happen over the course of 4 months after study onset.
Reduction in lumbar scoliotic curve
4 MONTHS AFTER STUDY ONSET4 MONTHS AFTER STUDY ONSET
Measured by the Cobb angle in coronal X-raysReduction in lumbar and thoracic scoliotic curve
3 MONTHS AFTER CROSSOVER GROUP INJECTIONS3 MONTHS AFTER CROSSOVER GROUP INJECTIONS
Measured by the Cobb angle in coronal X-raysPatient Q & A Section
Ask a question about the study
Other questions from users
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any geographic restrictions to consider when applying for this trial?
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
Will my insurance cover participating in this trial?
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.
See if you qualify for this trial
Get access to this novel treatment for Scoliosis; Lumbar Region by sharing your contact details with the study coordinator.